Breaking News

Dalton Adds SEC-MALS Testing Services

December 3, 2012

Supports large molecule production

Dalton Pharma Services has added SEC-MALS large molecule testing services for the development and manufacture of large molecules, such as proteins and polymers.
 
The company has acquired a new Size Exclusion Chromatography (SEC), Multi-Angle (Laser) Light Scattering (MALS) instrument to accurately measure the size and composition of large molecules. This technology replaces several manual testing methods, including viscosity, electrophoresis and chromatography retention times. It provides an absolute measure of molecular weight for molecules 10 to 1,000 nm in size.
 
“Having SEC-MALS provides Dalton with a specialized capability that supports large molecule products which are a growing part of our business,” said Peter Pekos, chief executive officer of Dalton. “We are constantly expanding our service offering to better meet the evolving needs of our customers. This is an example of how Dalton keeps up with the latest technologies in order to deliver the most efficient services.”

Related Contract Manufacturing:

blog comments powered by Disqus
  • FDA & Drug Development

    FDA & Drug Development

    Rachelle Du2019Souza, Regulatory Heights Inc.||September 8, 2016
    You must perform the necessary due diligence to stay on top of regulatory developments

  • The Role of Alliances in Modern Drug Development

    The Role of Alliances in Modern Drug Development

    Dr. Claire Madden-Smith, Senior Vice President, Juniper Pharma Services||September 8, 2016
    Combining expertise to get drug candidates through development

  • Limiting APIs in Manufacturing Effluent

    Limiting APIs in Manufacturing Effluent

    Joan Tell, Robert Drinane, Bruce Naumann, Jessica Vestel, and Gregory Gagliano, Merck & Co., Inc.||June 2, 2016
    An approach for setting limits on pharmaceuticals discharged in manufacturing effluent